Ipsen, Galderma increase collaboration for Dysport in new territories Ipsen and Galderma announced that their collaboration for the promotion and distribution of Dysport, Ipsenís botulinum toxin type A in aesthetic indications, has been extended. Both companies renewed their collaboration in Brazil and Argentina and extended their partnership to Australia where Galderma has the exclusive promotion and distribution rights for Ipsenís Dysport in glabellar lines indication. Both companies also entered into a co-promotion agreement in South Korea where Galderma and Ipsen will co-promote Dysport and Restylane.
News For IPSEY From The Last 14 Days
Check below for free stories on IPSEY the last two weeks.